Adial Pharmaceuticals (ADIL) Long-Term Investments (2023 - 2026)
Adial Pharmaceuticals (ADIL) posted Long-Term Investments of $241,000 for Q2 2026, down 86.1% from $1.73 million a year earlier and down 42.9% from the prior quarter.
Powered by 
Analysis
Adial Pharmaceuticals (ADIL) Long-Term Investments (2023 - 2026) Analysis & Trends
At the end of FY2025, Adial Pharmaceuticals' Long-Term Investments came in at $490,000, down 50.1% from FY2024.
- In prior years, Adial Pharmaceuticals' Long-Term Investments was $981,830 in FY2024 (-36.0%) and $1.53 million in FY2023.
- The Q2 2026 figure stands as the lowest quarterly Long-Term Investments in data going back to Q2 2023.
- On a year-over-year basis, Long-Term Investments has declined in each of the last three quarters, with an average decline of 17.9% over the last eight quarters.
- The strongest year-over-year quarter for Long-Term Investments in the past five years was Q3 2025, with growth of 58.4%; the weakest was Q2 2026, with a decline of 86.1%.
- According to Business Quant data, Long-Term Investments for the three prior quarters was $421,730 (Q1 2026), $490,000 (Q4 2025) and $1.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Adial Pharmaceuticals | 18.53 Mn | 18.53 Mn | - | 241,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 241,000.00 |
| Mar 31, 2026 | 421,730.00 |
| Dec 31, 2025 | 490,000.00 |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 981,830.00 |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.73 Mn |
API Access
Adial Pharmaceuticals Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ADIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ADIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ADIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();